LAG3 and head and neck squamous cell carcinoma: It is unfortunate that there are very few clinical studies that reported on BTLA in HNSCC, possibly due to the significantly higher expression of Slag-3 relative to BTLA in HNSCC, which may overshadow the biological impact of BTLA [82].